A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

  • Talmadge E. King Jr., Williamson Z. Bradford, Socorro Castro-Bernardini, Elizabeth A. Fagan, Ian Glaspole, Marilyn K. Glassberg, Eduard Gorina, Peter M. Hopkins, David Kardatzke, Lisa Lancaster, David J. Lederer, Steven D. Nathan, Carlos A. Pereira, Steven A. Sahn, Robert Sussman, Jeffrey J. Swigris, Paul W. Noble
  • New England Journal of Medicine, May 2014, New England Journal of Medicine (NEJM/MMS)
  • DOI: 10.1056/nejmoa1402582

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Anoop M Nambiar and David Lederer